Covestor’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
10
-6
-38% -$181 ﹤0.01% 2807
2026
Q2
$1K Buy
16
+12
+300% +$385 ﹤0.01% 2337
2026
Q1
$0 Buy
+4
New – ﹤0.01% 2744
2025
Q2
– Sell
-2,417
Closed -$16K – 2737
2025
Q1
$16K Buy
+2,417
New +$22.5K 0.01% 1269

Other funds holding STOK

Covestor's STOK Position: Q3 2026 in Review

Covestor reduced its Stoke Therapeutics (STOK) stake by 38% in Q3 2026, selling an estimated $181 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2807.

Covestor first reported a position in STOK in Q1 2025 and has held it in 4 quarters since. The position peaked at $16K in Q1 2025. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Covestor held 10 shares of Stoke Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 6 Stoke Therapeutics shares in Q3 2026, an estimated $181.
  • Stoke Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2807 holding.
  • Covestor first reported a position in Stoke Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Covestor's Stoke Therapeutics position peaked at $16K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.